Komori
ImageONE (2667) · InitiativeSoftened

Business integration through a share exchange with 創イノベーション

First written in FY2020-Q2. 6 of 7 entries say "Softened", first in FY2020. Latest entry: 2026-03-26.

7entries
7years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseSoftenedFY2020 – 2026-03-262020: 220202021: 120212022: 120222023: 020232024: 120242025: 120252026: 12026
Same theme, other companies
Management integration plan through a share exchange with 創イノベーションA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. 2026-03-26SoftenedM&A and Subsidiary Changes

    「As the prospects for commercializing this business remain unclear at this time, following the announcements dated 27 February 2020, 28 April 2020, 25 August 2020, 15 April 2021, 28 April 2022, 25 April 2023, 26 March 2024 and 28 March 2025 concerning changes to the schedule for the simplified share exchange between our company and 創イノベーション株式会社, we have again decided to change the scheduled date for the Board of Directors' approval and execution of the share exchange agreement to March 2027 (scheduled).」

    The scheduled execution and approval of the share exchange agreement with 創イノベーション株式会社 was postponed again from March 2026 to March 2027, and the share exchange date was postponed from June 2026 to June 2027.
  2. FY2024SoftenedAnnual report

    「The scheduled board approval and execution of the share exchange agreement was changed to March 2025.」

    The planned approval and execution of the agreement for the business integration with 創イノベーション was postponed to March 2025.
  3. FY2023SoftenedAnnual report

    「The scheduled board approval and execution of the share exchange agreement was changed to March 2024.」

    The planned execution of the agreement for the business integration with 創イノベーション was delayed further.
  4. FY2022SoftenedAnnual report

    「The scheduled board approval and execution of the share exchange agreement was changed to March 2023.」

    The planned approval and execution of the agreement for the business integration with 創イノベーション was postponed again to March 2023.
  5. FY2021SoftenedAnnual report

    「To continue discussions between the two companies on the terms and conditions of the share exchange, board approval and execution of the share exchange agreement had been scheduled for March 2021, but the schedule was changed to March 2022 for the same reason.」

    For the business integration with 創イノベーション, the planned approval and execution of the share exchange agreement changed from March 2021 to March 2022, further delaying implementation of the plan.
  6. FY2020SoftenedAnnual report

    「As the two companies will continue discussions on the terms and conditions of the share exchange, the schedule for the board meeting to approve the share exchange agreement and its execution has changed to March 2021.」

    The planned approval and execution of the share exchange agreement for the business integration with 創イノベーション was postponed from February 2020 to March 2021.
  7. FY2020-Q2First statedAnnual report

    「Regarding the basic agreement on business integration with 創イノベーション株式会社, aimed at accelerating efforts to create a clean energy society and promote regional revitalization, the board meeting to approve the share exchange agreement and its execution had been scheduled for February. However, as the two companies will continue discussions on the terms and conditions of the share exchange, the schedule for the board meeting to approve the agreement and its execution has changed from February to September.」

    A basic agreement on business integration through a share exchange was signed on 21 January 2020. The integration aims to create a clean energy society and promote regional revitalization, but the terms and conditions of the share exchange remain under discussion, and the planned agreement execution has changed from February to September.
Moved together

"Sales Concentration in 東京医療化学" moved the same way as this thread, in the same document, in 5 of its 7 moves.

544433★123456
  1. ★This thread
  2. 1Sales Concentration in 東京医療化学5×
  3. 2PACS: A Mature Market, with Further Adoption Potential for Cloud-Based Electronic Medical Records4×
  4. 3Integrating External Resources through M&A and Business Alliances4×
  5. 4Downside Risks to the Economy from the Slowdown in Emerging Markets, the UK's Withdrawal from the EU and Yen Appreciation4×
  6. 5Enhancing product competitiveness and profit margins in the medical imaging business3×
  7. 6Revenue Growth and Reduction in Operating, Ordinary and Net Losses3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for ImageONE yet. It last moved in the M&A and Subsidiary Changes of 2026-03-26: "Softened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Business integration through a share exchange with 創イノベーション | ImageONE Co.,Ltd. (2667) | Komori